Published in Parasite Immunol on July 28, 2008
CD8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS One (2011) 1.47
IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain. J Immunol (2012) 1.34
Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria. EMBO Mol Med (2013) 1.28
CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PLoS Pathog (2010) 1.22
Cerebral malaria: mysteries at the blood-brain barrier. Virulence (2012) 1.05
Caspase-1 activation of interleukin-1β (IL-1β) and IL-18 is dispensable for induction of experimental cerebral malaria. Infect Immun (2011) 1.02
S1P is associated with protection in human and experimental cerebral malaria. Mol Med (2011) 1.02
IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory T cells. PLoS Pathog (2015) 0.99
Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-gamma during Plasmodium berghei ANKA infection. J Immunol (2011) 0.93
Platelets present antigen in the context of MHC class I. J Immunol (2012) 0.91
Activated Brain Endothelial Cells Cross-Present Malaria Antigen. PLoS Pathog (2015) 0.89
Heme mediated STAT3 activation in severe malaria. PLoS One (2012) 0.88
Angiotensin II is a new component involved in splenic T lymphocyte responses during Plasmodium berghei ANKA infection. PLoS One (2013) 0.87
Pathogenic CD8+ T cells in experimental cerebral malaria. Semin Immunopathol (2015) 0.87
Microbial induction of vascular pathology in the CNS. J Neuroimmune Pharmacol (2010) 0.86
Vitamin D inhibits the occurrence of experimental cerebral malaria in mice by suppressing the host inflammatory response. J Immunol (2014) 0.85
Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria. PLoS One (2013) 0.84
Lipoxin A₄ and 15-epi-lipoxin A₄ protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brain. PLoS One (2013) 0.84
Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity? Fluids Barriers CNS (2014) 0.84
Protein kinase C θ deficiency increases resistance of C57BL/6J mice to Plasmodium berghei infection-induced cerebral malaria. Infect Immun (2010) 0.83
CCL3L1 copy number and susceptibility to malaria. Infect Genet Evol (2012) 0.83
Cerebral malaria: gamma-interferon redux. Front Cell Infect Microbiol (2014) 0.81
Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy. Eur J Clin Microbiol Infect Dis (2010) 0.81
Dietary restriction protects against experimental cerebral malaria via leptin modulation and T-cell mTORC1 suppression. Nat Commun (2015) 0.81
Specific depletion of Ly6C(hi) inflammatory monocytes prevents immunopathology in experimental cerebral malaria. PLoS One (2015) 0.81
Interferon-γ: The Jekyll and Hyde of Malaria. PLoS Pathog (2015) 0.80
Adjuvant activity of naturally occurring monophosphoryl lipopolysaccharide preparations from mucosa-associated bacteria. Infect Immun (2013) 0.79
Maladjusted host immune responses induce experimental cerebral malaria-like pathology in a murine Borrelia and Plasmodium co-infection model. PLoS One (2014) 0.79
Parasite-Specific CD4+ IFN-γ+ IL-10+ T Cells Distribute within Both Lymphoid and Nonlymphoid Compartments and Are Controlled Systemically by Interleukin-27 and ICOS during Blood-Stage Malaria Infection. Infect Immun (2015) 0.78
Interferons and interferon regulatory factors in malaria. Mediators Inflamm (2014) 0.77
Defibrotide: a Swiss Army knife intervention in the battle against cerebral malaria. Arterioscler Thromb Vasc Biol (2012) 0.76
Plasmodium-infected erythrocytes (pRBC) induce endothelial cell apoptosis via a heme-mediated signaling pathway. Drug Des Devel Ther (2016) 0.76
Experimental Models of Microvascular Immunopathology: The Example of Cerebral Malaria. J Neuroinfect Dis (2014) 0.76
Endothelial-Leukocyte Interaction in Severe Malaria: Beyond the Brain. Mediators Inflamm (2015) 0.76
Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice. Infect Immun (2015) 0.75
Behavioural and neurological symptoms accompanied by cellular neuroinflammation in IL-10-deficient mice infected with Plasmodium chabaudi. Malar J (2016) 0.75
Simultaneously targeting inflammatory response and parasite sequestration in brain to treat Experimental Cerebral Malaria. Sci Rep (2015) 0.75
A role for the histone H2A deubiquitinase MYSM1 in maintenance of CD8+ T cells. Immunology (2017) 0.75
Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria. Infect Immun (2014) 0.75
Splenic differentiation and emergence of CCR5(+)CXCL9(+)CXCL10(+) monocyte-derived dendritic cells in the brain during cerebral malaria. Nat Commun (2016) 0.75
Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis. PLoS One (2015) 0.75
Parasite densities modulate susceptibility of mice to cerebral malaria during co-infection with Schistosoma japonicum and Plasmodium berghei. Malar J (2014) 0.75
IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria. Infect Immun (2015) 0.75
Suppression of CD4+ Effector Responses by Naturally Occurring CD4+ CD25+ Foxp3+ Regulatory T Cells Contributes to Experimental Cerebral Malaria. Infect Immun (2015) 0.75
Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism. J Biol Chem (2016) 0.75
IFN-γ mediates Experimental Cerebral Malaria by signalling within both the hematopoietic and non- hematopoietic compartments. Infect Immun (2017) 0.75
IL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malaria. PLoS Pathog (2017) 0.75
Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. J Immunol (1987) 2.91
Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation. Br J Psychiatry (2011) 2.75
Evidence for reactive oxygen intermediates causing hemolysis and parasite death in malaria. Infect Immun (1983) 2.59
L-arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation. Eur J Immunol (1991) 1.95
Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology (1992) 1.78
Possible roles of tumor necrosis factor in the pathology of malaria. Am J Pathol (1987) 1.69
Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger. J Am Acad Dermatol (1987) 1.68
Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur J Immunol (2000) 1.68
A systematic approach to analyse health-related quality of life in multiple sclerosis: the GEDMA study. Mult Scler (2004) 1.62
Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation. J Immunol (1986) 1.58
Precisely timed spatiotemporal patterns of neural activity in dissociated cortical cultures. Neuroscience (2007) 1.52
Experimental models of cerebral malaria. Curr Top Microbiol Immunol (2005) 1.50
Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology (1988) 1.47
Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr (2000) 1.45
Survival of rodent malaria merozoites in the lymphatic network: potential role in chronicity of the infection. Parasite (1999) 1.42
Early activation of microglia in the pathogenesis of fatal murine cerebral malaria. Glia (1997) 1.32
Diagnosis of classical galactosaemia. Arch Dis Child (1977) 1.32
Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Am J Pathol (1998) 1.32
Submerged bacterial colonies within food and model systems: their growth, distribution and interactions. Int J Food Microbiol (1995) 1.28
Antioxidants inhibit proliferation and cell surface expression of receptors for interleukin-2 and transferrin in T lymphocytes stimulated with phorbol myristate acetate and ionomycin. Cell Immunol (1988) 1.27
Free radical-induced pathology. Med Res Rev (1985) 1.26
In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated malaria sporozoites, malaria blood parasites or adjuvants. Eur J Immunol (1993) 1.24
Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria. Infect Immun (1998) 1.22
Early microvascular changes in murine cerebral malaria detected in retinal wholemounts. Am J Pathol (1992) 1.19
Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria. Am J Pathol (1996) 1.17
A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'. EMBO J (1999) 1.17
Recruitment of ethnic minorities into cancer clinical trials: experience from the front lines. Br J Cancer (2012) 1.15
Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes. Am J Pathol (1997) 1.14
Redistribution and degeneration of retinal astrocytes in experimental murine cerebral malaria: relationship to disruption of the blood-retinal barrier. Glia (1996) 1.14
Stage-specific transcription of distinct repertoires of a multigene family during Plasmodium life cycle. Science (2002) 1.14
Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice. Science (2000) 1.13
Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology. Proc Natl Acad Sci U S A (1994) 1.12
Conventional and experimental treatment of cerebral malaria. Int J Parasitol (2006) 1.12
Central nervous system in cerebral malaria: 'Innocent bystander' or active participant in the induction of immunopathology? Immunol Cell Biol (2001) 1.12
Effect of guanyl nucleotides on parathyroid hormone-responsive adenylate cyclase in chick kidney. J Endocrinol (1976) 1.10
Oxygen-derived free radicals in the pathogenesis of parasitic disease. Adv Parasitol (1986) 1.08
TNF inhibits malaria hepatic stages in vitro via synthesis of IL-6. Int Immunol (1991) 1.07
Inhibitory activity of IL-6 on malaria hepatic stages. Parasite Immunol (1991) 1.06
Peptide-primed CD4+ cells and malaria sporozoites. Immunol Lett (1990) 1.05
Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase. Parasite Immunol (2000) 1.04
Possible mechanisms responsible for the increased ascorbic acid content of Plasmodium vinckei-infected mouse erythrocytes. Biochim Biophys Acta (1986) 1.04
Parathyroid hormone-responsive adenylate cyclase in induced transplantable osteogenic rat sarcoma. Nature (1976) 1.03
Toxicity of peracetic acid (PAA) to tomonts of IIchthyophthirius multifiliis. Dis Aquat Organ (2009) 1.03
Comparisons between microvascular changes in cerebral and non-cerebral malaria in mice, using the retinal whole-mount technique. Parasitology (1993) 1.03
Is ischemia involved in the pathogenesis of murine cerebral malaria? Am J Pathol (2001) 1.02
Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line. Br J Cancer (1977) 1.02
Pathogenicity and histopathology of an unusually intense infection of white grubs (Posthodiplostomum m. minimum) in the fathead minnow (Pimephales promelas). J Wildl Dis (1982) 1.01
Hepatic phase of malaria is the target of cellular mechanisms induced by the previous and the subsequent stages. A crucial role for liver nonparenchymal cells. Immunol Lett (1990) 1.01
Inhibition of Plasmodium yoelii blood-stage malaria by interferon alpha through the inhibition of the production of its target cell, the reticulocyte. Blood (2001) 1.01
Antioxidants inhibit indoleamine 2,3-dioxygenase in IFN-gamma-activated human macrophages: posttranslational regulation by pyrrolidine dithiocarbamate. J Immunol (2001) 1.00
ERK activation and mitogenesis in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2001) 1.00
Antioxidants can prevent cerebral malaria in Plasmodium berghei-infected mice. Br J Exp Pathol (1989) 0.99
A method for the quantitative assessment of malaria parasite development in organs of the mammalian host. Mol Biochem Parasitol (1996) 0.98
Role of 3',5'-cyclic AMP in glucagon-induced stimulation of ruthenium red-insensitive calcium transport in an endoplasmic reticulum-rich fraction of rat liver. FEBS Lett (1980) 0.98
Epidermodysplasia verruciformis. A case associated with primary lymphatic dysplasia, depressed cell-mediated immunity, and Bowen's disease containing human papillomavirus 16 DNA. Arch Dermatol (1987) 0.97
Impaired health-related quality of life predicts progression of disability in multiple sclerosis. Eur J Neurol (2012) 0.97
Cyclic AMP and the regulation of prostaglandin production by macrophages. Biochem Biophys Res Commun (1983) 0.96
Secretion of prostaglandins as bone-resorbing agents by renal cortical carcinoma in culture. Br J Cancer (1977) 0.96
Differentiation of Trypanosoma cruzi epimastigotes: metacyclogenesis and adhesion to substrate are triggered by nutritional stress. J Parasitol (2000) 0.95
Autoreactive T cell clones of MHC class II specificities are produced during responses against foreign antigens in man. J Immunol (1987) 0.95
Primary proliferative T cell response to wild-type p53 protein in patients with breast cancer. Eur J Immunol (1995) 0.95
Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria. Glia (1997) 0.95
Co-infection of malaria with HIV: an immunological perspective. Parasite Immunol (2006) 0.95
Iron overload increases hepatic development of Plasmodium yoelii in mice. Parasitology (1996) 0.95
Passive but not active CD8+ T cell-based immunotherapy interferes with liver tumor progression in a transgenic mouse model. J Immunol (1998) 0.93
Serodiagnosis of chronic Chagas infection by using EIE-Recombinant-Chagas-Biomanguinhos kit. Mem Inst Oswaldo Cruz (2001) 0.92
Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection. Int Immunol (1997) 0.92
Obesity and impaired cognitive functioning in the elderly: a population-based cross-sectional study (NEDICES). Eur J Neurol (2013) 0.92
Expression of the erythrocyte-binding antigen 175 in sporozoites and in liver stages of Plasmodium falciparum. J Infect Dis (2001) 0.92
Immunization with the malaria heat shock like protein hsp70-1 enhances transmission to the mosquito. Int Immunol (1995) 0.91
Redox regulation of the mitogen-activated protein kinase pathway during lymphocyte activation. Biochim Biophys Acta (1997) 0.91
Activity of doxycycline against preerythrocytic malaria. J Infect Dis (1993) 0.91
The activity of Escherichia coli dihydroorotate dehydrogenase is dependent on a conserved loop identified by sequence homology, mutagenesis, and limited proteolysis. Biochemistry (1999) 0.90
Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2. Amino Acids (2010) 0.90
Serum insulin and somatomedin levels in the tumour-bearing rat. Eur J Cancer (1975) 0.90
Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr (1998) 0.90
Cyclic nucleotide excretion in human malignancies. Clin Sci (Lond) (1980) 0.90
Oxidative stress and protective mechanisms in erythrocytes in relation to Plasmodium vinckei load. Proc Natl Acad Sci U S A (1985) 0.90
Production of luminol-reactive oxygen radicals during Plasmodium vinckei infection. Infect Immun (1984) 0.89
Tissue distribution of indoleamine 2,3-dioxygenase in normal and malaria-infected tissue. Redox Rep (2000) 0.89
RMI 12330A, an inhibitor of cyclic nucleotide phosphodiesterases and adenylate cyclase in kidney preparations. Biochim Biophys Acta (1980) 0.89
Role of vasopressin in the mitotic response of rat bone marrow cells to haemorrhage. J Endocrinol (1977) 0.89
Redox metabolism of vitamin C in blood of normal and malaria-infected mice. Biochim Biophys Acta (1993) 0.89
Subcutaneous alternariosis. J Am Acad Dermatol (1983) 0.88
Use of a tuberculin purified protein derivative--Asn-Ala-Asn-Pro conjugate in bacillus Calmette-Guérin primed mice overcomes H-2 restriction of the antibody response and avoids the need for adjuvants. Proc Natl Acad Sci U S A (1990) 0.88
Phagocyte-derived reactive oxygen species do not influence the progression of murine blood-stage malaria infections. Infect Immun (2005) 0.88
Alopecia areata: pathogenesis and treatment. J Am Acad Dermatol (1984) 0.88
Effects of endotoxin and dexamethasone on cerebral malaria in mice. Parasitology (1995) 0.88
Are reactive oxygen species involved in the pathogenesis of murine cerebral malaria? J Infect Dis (1999) 0.88
Fas and perforin contribute to the pathogenesis of murine cerebral malaria. Redox Rep (1999) 0.87
Functional symptoms in neurology: questions and answers. J Neurol Neurosurg Psychiatry (2005) 0.87
Activity of divicine in Plasmodium vinckei-infected mice has implications for treatment of favism and epidemiology of G-6-PD deficiency. Br J Haematol (1984) 0.87
Development of the "activated" high resolution 1H MR spectrum in murine T cells and B cells occurs in G1 phase of the cell cycle. Magn Reson Med (1990) 0.87
Development of irreversible lesions in the brain, heart and kidney following acute and chronic murine malaria infection. Parasitology (1999) 0.87
The quality of psychotropic drug prescribing in patients in psychiatric units for the elderly. Aging Ment Health (2002) 0.87
Detection of short-chain carbonyl products of lipid peroxidation from malaria-parasite (Plasmodium vinckei)-infected red blood cells exposed to oxidative stress. Biochem J (1988) 0.86
Toxicity of certain products of lipid peroxidation to the human malaria parasite Plasmodium falciparum. Biochem Pharmacol (1987) 0.86